Mortality and other adverse outcomes in patients with type 2 diabetes mellitus admitted for COVID-19 in association with glucose-lowering drugs: a nationwide cohort study (Q102062545)
Jump to navigation
Jump to search
scientific article published on 16 November 2020
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Mortality and other adverse outcomes in patients with type 2 diabetes mellitus admitted for COVID-19 in association with glucose-lowering drugs: a nationwide cohort study |
scientific article published on 16 November 2020 |
Statements
Mortality and other adverse outcomes in patients with type 2 diabetes mellitus admitted for COVID-19 in association with glucose-lowering drugs: a nationwide cohort study (English)
Luis M Pérez-Belmonte
José David Torres-Peña
María D López-Carmona
M Mar Ayala-Gutiérrez
Francisco Fuentes-Jiménez
Lucía Jorge Huerta
Jaime Alonso Muñoz
Manuel Rubio-Rivas
Manel Madrazo
Marcos Guzmán Garcia
Beatriz Vicente Montes
Joaquim Fernández Sola
Javier Ena
Ruth Gonzalez Ferrer
Carmen Mella Pérez
Carlos Jorge Ripper
Jose Javier Napal Lecumberri
Iris El Attar Acedo
Susana Plaza Canteli
Sara Fuente Cosío
Francisco Amorós Martínez
Begoña Cortés Rodríguez
Pablo Pérez-Martínez
José Manuel Ramos-Rincón
Ricardo Gómez-Huelgas
SEMI-COVID-19 Network
16 November 2020